This topic contains a solution. Click here to go to the answer

Author Question: A nonspecific-treatment control group a) Is designed to control for common factors that are ... (Read 102 times)

cabate

  • Hero Member
  • *****
  • Posts: 537
A nonspecific-treatment control group
 
  a) Is designed to control for common factors that are associated with treatment
  b) Rules out the role of expectancies in explaining why clients get better
  c) Controls for placebo effects in a medication study
  d) Is the best way to rule out threats to internal validity (e.g., regression, testing)

Question 2

Why are waiting-list control groups more favorable than no-treatment control groups?
 
  a) They allow for both between and within-participant comparisons.
  b) Every participant will receive the treatment at the same time.
  c) It eliminates all ethical concerns for methodology.
  d) The control group is not impacted by contact with the experiment.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

strudel15

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

Correct Answer: a

Answer to Question 2

Correct Answer: a




cabate

  • Member
  • Posts: 537
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)


tanna.moeller

  • Member
  • Posts: 328
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

For a complete list of videos, visit our video library